Susquehanna International Group, LLP Cerus Corp Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Cerus Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 250,987 shares of CERS stock, worth $328,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,987
Previous 212,739 17.98%
Holding current value
$328,792
Previous $327,000 6.42%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$1.39 - $2.15 $53,164 - $82,233
38,248 Added 17.98%
250,987 $348,000
Q4 2024

Feb 14, 2025
BUY
$1.52 - $2.03 $26,213 - $35,009
17,246 Added 8.82%
212,739 $327,000
Q3 2024

Nov 14, 2024
SELL
$1.7 - $2.39 $118,479 - $166,568
-69,694 Reduced 26.28%
195,493 $340,000
Q2 2024

Aug 15, 2024
BUY
$1.62 - $2.04 $349,192 - $439,724
215,551 Added 434.26%
265,187 $466,000
Q1 2024

May 07, 2024
SELL
$1.66 - $2.42 $786,383 - $1.15 Million
-473,725 Reduced 90.52%
49,636 $93,000
Q4 2023

Feb 14, 2024
BUY
$1.25 - $2.35 $358,142 - $673,307
286,514 Added 120.97%
523,361 $1.13 Million
Q3 2023

Nov 14, 2023
SELL
$1.5 - $3.07 $214,194 - $438,383
-142,796 Reduced 37.61%
236,847 $383,000
Q2 2023

Aug 11, 2023
BUY
$1.79 - $2.9 $136,190 - $220,643
76,084 Added 25.06%
379,643 $933,000
Q1 2023

May 16, 2023
BUY
$2.65 - $3.81 $43,592 - $62,674
16,450 Added 5.73%
303,559 $901,000
Q4 2022

Feb 14, 2023
SELL
$3.38 - $4.22 $652,441 - $814,586
-193,030 Reduced 40.2%
287,109 $1.05 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $902,628 - $1.53 Million
263,157 Added 121.28%
480,139 $1.73 Million
Q2 2022

Aug 15, 2022
BUY
$4.41 - $5.69 $153,644 - $198,239
34,840 Added 19.13%
216,982 $1.15 Million
Q1 2022

May 16, 2022
SELL
$4.81 - $6.99 $14,155 - $20,571
-2,943 Reduced 1.59%
182,142 $1 Million
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $153,423 - $203,793
-25,699 Reduced 12.19%
185,085 $1.26 Million
Q3 2021

Nov 15, 2021
SELL
$4.79 - $6.68 $261,979 - $365,349
-54,693 Reduced 20.6%
210,784 $1.28 Million
Q2 2021

Aug 11, 2021
SELL
$5.35 - $6.35 $263,792 - $313,099
-49,307 Reduced 15.66%
265,477 $1.57 Million
Q1 2021

May 17, 2021
SELL
$5.68 - $7.87 $704,870 - $976,643
-124,097 Reduced 28.28%
314,784 $1.89 Million
Q4 2020

Feb 16, 2021
BUY
$5.25 - $8.56 $597,019 - $973,426
113,718 Added 34.97%
438,881 $3.04 Million
Q3 2020

Nov 16, 2020
BUY
$5.78 - $7.47 $1.51 Million - $1.95 Million
260,612 Added 403.73%
325,163 $2.04 Million
Q2 2020

Aug 14, 2020
SELL
$4.5 - $7.02 $609,304 - $950,515
-135,401 Reduced 67.72%
64,551 $426,000
Q1 2020

May 15, 2020
BUY
$2.87 - $5.49 $225,122 - $430,635
78,440 Added 64.55%
199,952 $930,000
Q4 2019

Feb 14, 2020
BUY
$3.84 - $4.86 $224,640 - $284,310
58,500 Added 92.84%
121,512 $513,000
Q3 2019

Nov 14, 2019
SELL
$4.86 - $6.05 $275,362 - $342,786
-56,659 Reduced 47.35%
63,012 $325,000
Q2 2019

Aug 16, 2019
BUY
$4.51 - $6.6 $209,516 - $306,609
46,456 Added 63.45%
119,671 $672,000
Q2 2019

Aug 14, 2019
SELL
$4.51 - $6.6 $818,190 - $1.2 Million
-181,417 Reduced 71.25%
73,215 $411,000
Q4 2018

Feb 14, 2019
BUY
$4.89 - $7.16 $435,058 - $637,018
88,969 Added 53.7%
254,632 $1.29 Million
Q3 2018

Nov 14, 2018
BUY
$6.89 - $7.78 $428,861 - $484,258
62,244 Added 60.19%
165,663 $1.19 Million
Q2 2018

Aug 14, 2018
BUY
$5.19 - $7.25 $144,282 - $201,550
27,800 Added 36.76%
103,419 $690,000
Q1 2018

May 15, 2018
SELL
$3.56 - $5.74 $282,229 - $455,055
-79,278 Reduced 51.18%
75,619 $414,000
Q4 2017

Feb 14, 2018
BUY
$2.76 - $3.95 $78,850 - $112,847
28,569 Added 22.61%
154,897 $524,000
Q3 2017

Nov 14, 2017
BUY
$2.22 - $2.73 $280,448 - $344,875
126,328
126,328 $345,000

Others Institutions Holding CERS

# of Institutions
163
Shares Held
147M
Call Options Held
24.2K
Put Options Held
44.4K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $232M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email